BRPF1-IN-3

CAS No. 901245-65-6

BRPF1-IN-3 ( GSK-5959; GSK 5959; GSK5959. )

Catalog No. M16481 CAS No. 901245-65-6

BRPF1-IN-3 is a potent, selective, membrane permeable BRPF1 bromodomain inhibitor with pIC50 of 7.1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 47 In Stock
10MG 80 In Stock
25MG 143 In Stock
50MG 237 In Stock
100MG 353 In Stock
200MG 516 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    BRPF1-IN-3
  • Note
    Research use only, not for human use.
  • Brief Description
    BRPF1-IN-3 is a potent, selective, membrane permeable BRPF1 bromodomain inhibitor with pIC50 of 7.1.
  • Description
    BRPF1-IN-3 is a potent, selective, membrane permeable BRPF1 bromodomain inhibitor with pIC50 of 7.1; shows 100- and >1000-fold selectivity over BRPF2 and BRPF3, respectively; exhibits an IC50 of 0.98 uM in cellular protein interaction assay (displacement of NanoLuc-tagged BRPF1 bromodomain from Halo-tagged histone H3.3).
  • Synonyms
    GSK-5959; GSK 5959; GSK5959.
  • Pathway
    Chromatin/Epigenetic
  • Target
    Bromodomain
  • Recptor
    BRPF1
  • Research Area
    Other Indications
  • Indication
    ——

Chemical Information

  • CAS Number
    901245-65-6
  • Formula Weight
    394.48
  • Molecular Formula
    C22H26N4O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO: 10 mM ( < 1 mg/ml refers to the product slightly soluble or insoluble )
  • SMILES
    O=C(NC1=C(N2CCCCC2)C=C(N3C)C(N(C)C3=O)=C1)C4=CC=CC=C4OC
  • Chemical Name
    N-(1,3-dimethyl-2-oxo-6-(piperidin-1-yl)-2,3-dihydro-1H-benzo[d]imidazol-5-yl)-2-methoxybenzamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • AZD5153 6-Hydroxy-2-...

    A potent, selective, bivalent and orally available BET/BRD4 bromodomain with IC50 of 5 nM.

  • MS-417

    MS-417 (GTPL-7512) is a highly specific BET bromodomain inhibitor that binds to BRD4-BD1 and BRD4 BD2 with Kd of 36.1 uM and 25.4 uM respectively.

  • GNE-781

    GNE-781 (GNE781) is a potent, selective, non-CNS penetrant, orally active CBP/p300 bromodomain inhibitor.